Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Polish bValue closes Growth fund with total cap of €90m
Warsaw-based investment firm bValue has announced the closing of its third fund, bValue Growth (BVG), at €90 million to support technological companies in Poland and across Central and Eastern Europe. bValue was founded in 2016 by Maciej Balsewicz as early-stage tech...
Blackstone signs over $1bn deal with MBK for 1st exit in Korea
The US asset manager will sell a 71.25% stake in drug wholesaler Geo-Young, the corporate value of which is around $1.4 billion. Private equity giant Blackstone Inc. is set to mark its first exit from South Korea by selling a 71.25% stake in the holding firm of...
CVC aims at up to $16bn valuation in Amsterdam IPO
CVC Capital Partners is targeting a market capitalisation as high as 15 billion euros ($16 billion) in its initial public offering (IPO), the private equity group said on Monday. The company is offering shares at a price range of 13 to 15 euros, with trading on...